JavaScript seems to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.

Human Fibrinogen (FBG) AssayMax ELISA Kit

Human Fibrinogen (FBG) AssayMax ELISA Kit

Move your mouse over image or click to enlarge

Human Fibrinogen (FBG) AssayMax ELISA Kit

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.

View Datasheet

Cat#	Size	Price	Qty	Buy
EF1040-2	96 Well Plate	£260.00

Additional Information

Property	Value or Rating
Manufacturer	Assaypro, LLC.
Product Type	AssayMax™ ELISA Kits
Species	Human
Assay Format	Competitive ELISA
Product Size	96 Well Plate
Range	2.5-40 ug/ml
Plex Number	1
Storage	Refer to component labels for details
Entrez Gene	2243, 2244, 2266
Omim	134820, 134830, 134850
UniProt	P02671, P02675, P02679
UniGene	Hs.351593, Hs.300774, Hs.727584
Special Notes	For Research Use Only, Not To Be Used For Diagnostic Purposes
References	* Fukuda J et al. (2003) Efficacy of a Polyurethane Foam/Spheroid Artificial Liver by Using Human Hepatoblastoma Cell Line (Hep G2). Cell Transplantation 12(1):51-58 * Alston SM Jr. (2005) Autologous fibrinogen purification and concentration for use in fibrin sealant. Ph.D. Dissertation, Department of Chemical Engineering, Brigham Young University * Fukuda J et al. (2005) Differentiation Effects by the Combination of Spheroid Formation and Sodium Butyrate Treatment in Human Hepatoblastoma Cell Line (Hep G2): A Possible Cell Source for Hybrid Artificial Liver. Cell Transplantation 14(10):819-827 * Alston SM et al. (2007) New method to prepare autologous fibrin glue on demand. Transl Res. 48:1191-1200 * Brohi K et al. (2007) Acute Traumatic Coagulopathy: Initiated by Hypoperfusion: Modulated Through the Protein C Pathway? Annals of Surgery 245(5):812-818 * Cohen MJ et al. (2007) Early Coagulopathy After Traumatic Brain Injury: The Role of Hypoperfusion and the Protein C Pathway. Journal of Trauma-Injury Infection & Critical Care. 63(6):1254-1262 * Alston SM et al. (2008) In vivo efficacy of a new autologous fibrin sealant. J Surg Res. 146(1):143-148 * Mohammed S et al. (2008) Methods of making concentrated fibrinogen containing compositions and associated systems for preparing fibrin glue. USPTO Patent Applicaton #: 20080267940 * Perry CD et al. (2008) Centrally located body fat is related to inflammatory markers in healthy postmenopausal women. Menopause 15(4):619-627 * Jindal R et al. (2009) Amino acid-mediated heterotypic interaction governs performance of a hepatic tissue model. FASEB J. 23(7):2288-2298 * Lemmers A et al. (2009) An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease. Clin Exp Immunol. 156(3): 518-527 * Matvienko OA et al. (2010) Androidal Fat Dominates in Predicting Cardiometabolic Risk in Postmenopausal Women. Cardiol Res Pract. 2011:904878 * Krysiak R and Okopien B (2011) Haemostatic effects of simvastatin in subjects with impaired glucose tolerance. Intern Med J. 41(6):473-481 * Ekwere T et al. (2013) Assessment of some plasma fibrinolytic proteins in sickle cell anemia patients in steady state and in vaso-occlusive crises. Journal of Applied Hematology. 4(4):131-136 * Ou-Yang MC et al. (2013) Plasma Clusterin Concentrations May Predict Resistance to Intravenous Immunoglobulin in Patients with Kawasaki Disease. The Scientific World Journal. 2013: 382523, 5 pages * Beyerle A et al. (2014) Analysis of the safety and pharmacodynamics of human fibrinogen concentrate in animals. Toxicol Appl Pharmacol. 280(1):70-7 " title=" * Fukuda J et al. (2003) Efficacy of a Polyurethane Foam/Spheroid Artificial Liver by Using Human Hepatoblastoma Cell Line (Hep G2). Cell Transplantation 12(1):51-58 * Alston SM Jr. (2005) Autologous fibrinogen purification and concentration for use in fibrin sealant. Ph.D. Dissertation, Department of Chemical Engineering, Brigham Young University * Fukuda J et al. (2005) Differentiation Effects by the Combination of Spheroid Formation and Sodium Butyrate Treatment in Human Hepatoblastoma Cell Line (Hep G2): A Possible Cell Source for Hybrid Artificial Liver. Cell Transplantation 14(10):819-827 * Alston SM et al. (2007) New method to prepare autologous fibrin glue on demand. Transl Res. 48:1191-1200 * Brohi K et al. (2007) Acute Traumatic Coagulopathy: Initiated by Hypoperfusion: Modulated Through the Protein C Pathway? Annals of Surgery 245(5):812-818 * Cohen MJ et al. (2007) Early Coagulopathy After Traumatic Brain Injury: The Role of Hypoperfusion and the Protein C Pathway. Journal of Trauma-Injury Infection & Critical Care. 63(6):1254-1262 * Alston SM et al. (2008) In vivo efficacy of a new autologous fibrin sealant. J Surg Res. 146(1):143-148 * Mohammed S et al. (2008) Methods of making concentrated fibrinogen containing compositions and associated systems for preparing fibrin glue. USPTO Patent Applicaton #: 20080267940 * Perry CD et al. (2008) Centrally located body fat is related to inflammatory markers in healthy postmenopausal women. Menopause 15(4):619-627 * Jindal R et al. (2009) Amino acid-mediated heterotypic interaction governs performance of a hepatic tissue model. FASEB J. 23(7):2288-2298 * Lemmers A et al. (2009) An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease. Clin Exp Immunol. 156(3): 518-527 * Matvienko OA et al. (2010) Androidal Fat Dominates in Predicting Cardiometabolic Risk in Postmenopausal Women. Cardiol Res Pract. 2011:904878 * Krysiak R and Okopien B (2011) Haemostatic effects of simvastatin in subjects with impaired glucose tolerance. Intern Med J. 41(6):473-481 * Ekwere T et al. (2013) Assessment of some plasma fibrinolytic proteins in sickle cell anemia patients in steady state and in vaso-occlusive crises. Journal of Applied Hematology. 4(4):131-136 * Ou-Yang MC et al. (2013) Plasma Clusterin Concentrations May Predict Resistance to Intravenous Immunoglobulin in Patients with Kawasaki Disease. The Scientific World Journal. 2013: 382523, 5 pages * Beyerle A et al. (2014) Analysis of the safety and pharmacodynamics of human fibrinogen concentrate in animals. Toxicol Appl Pharmacol. 280(1):70-7 " target="_blank"> * Fukuda J et al. (2003) Efficacy of a Polyurethane Foam/Spheroid Artificial Liver by Using Human Hepatoblastoma Cell Line (Hep G2). Cell Transplantation 12(1):51-58 * Alston SM Jr. (2005) Autologous fibrinogen purification and concentration for use in fibrin sealant. Ph.D. Dissertation, Department of Chemical Engineering, Brigham Young University * Fukuda J et al. (2005) Differentiation Effects by the Combination of Spheroid Formation and Sodium Butyrate Treatment in Human Hepatoblastoma Cell Line (Hep G2): A Possible Cell Source for Hybrid Artificial Liver. Cell Transplantation 14(10):819-827 * Alston SM et al. (2007) New method to prepare autologous fibrin glue on demand. Transl Res. 48:1191-1200 * Brohi K et al. (2007) Acute Traumatic Coagulopathy: Initiated by Hypoperfusion: Modulated Through the Protein C Pathway? Annals of Surgery 245(5):812-818 * Cohen MJ et al. (2007) Early Coagulopathy After Traumatic Brain Injury: The Role of Hypoperfusion and the Protein C Pathway. Journal of Trauma-Injury Infection & Critical Care. 63(6):1254-1262 * Alston SM et al. (2008) In vivo efficacy of a new autologous fibrin sealant. J Surg Res. 146(1):143-148 * Mohammed S et al. (2008) Methods of making concentrated fibrinogen containing compositions and associated systems for preparing fibrin glue. USPTO Patent Applicaton #: 20080267940 * Perry CD et al. (2008) Centrally located body fat is related to inflammatory markers in healthy postmenopausal women. Menopause 15(4):619-627 * Jindal R et al. (2009) Amino acid-mediated heterotypic interaction governs performance of a hepatic tissue model. FASEB J. 23(7):2288-2298 * Lemmers A et al. (2009) An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease. Clin Exp Immunol. 156(3): 518-527 * Matvienko OA et al. (2010) Androidal Fat Dominates in Predicting Cardiometabolic Risk in Postmenopausal Women. Cardiol Res Pract. 2011:904878 * Krysiak R and Okopien B (2011) Haemostatic effects of simvastatin in subjects with impaired glucose tolerance. Intern Med J. 41(6):473-481 * Ekwere T et al. (2013) Assessment of some plasma fibrinolytic proteins in sickle cell anemia patients in steady state and in vaso-occlusive crises. Journal of Applied Hematology. 4(4):131-136 * Ou-Yang MC et al. (2013) Plasma Clusterin Concentrations May Predict Resistance to Intravenous Immunoglobulin in Patients with Kawasaki Disease. The Scientific World Journal. 2013: 382523, 5 pages * Beyerle A et al. (2014) Analysis of the safety and pharmacodynamics of human fibrinogen concentrate in animals. Toxicol Appl Pharmacol. 280(1):70-7

Related Documents